Year-over-year, this metric declined by 56.9%, from $65.00M to $28.00M. Over 2 years (FY 2022 to FY 2025), Other Income (Expense) shows an upward trend with a 157.1% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$23.75M | -$23.75M | -$23.75M | -$23.75M | $171.00M | $342.00M | $220.00M | $214.00M | $259.00M | $28.00M | $65.00M | $521.00M | $42.00M | $0.00 | $28.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +820.0% | +100.0% | -35.7% | -2.7% | +21.0% | -89.2% | +132.1% | +701.5% | -91.9% | -100.0% | — |
| YoY Change | — | — | — | — | +820.0% | >999% | — | — | +51.5% | -91.8% | -70.5% | +143.5% | -83.8% | -100.0% | -56.9% |